Figures computed from official regulatory filings — .
Ownershipinsiders 48.01% · institutions 10.86%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for CELLECTIS only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
11 buys8 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Steven H. DOARES | Buy | $13.9K | conv 64First in 12mo |
| AMF |
| Donald A. Bergstrom | Buy | $45.7K | conv 50 | AMF |
| Donald A. Bergstrom | Buy | $51.2K | conv 64First in 12mo | AMF |
| MARIE-BLEUENN TERRIER | Sell | $122.9K | AMF |
| DAVID SOURDIVE | Sell | $20.8K | Unusual size | AMF |
| DAVID SOURDIVE | Sell | $229.1K | AMF |
| DAVID SOURDIVE | Sell | $183.5K | AMF |
| Andre Choulika | Sell | $1.5M | AMF |
| DAVID SOURDIVE | Sell | $116.9K | AMF |
| ARTHUR STRIL | Sell | $315.8K | AMF |
| ARTHUR STRIL | Buy | $126.9K | conv 76 | AMF |
| MARIE-BLEUENN TERRIER | Sell | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| KYUNG NAM-WORTMAN | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 83ClusterFirst in 12mo | AMF |
| MARIE-BLEUENN TERRIER | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 77ClusterFirst in 12mo | AMF |
| ARTHUR STRIL | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 92ClusterFirst in 12mo | AMF |
| STEPHAN REYNIER | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 83ClusterFirst in 12mo | AMF |
| STEVEN DOARES | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 83ClusterFirst in 12mo | AMF |
| PHILIPPE DUCHATEAU | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 83ClusterFirst in 12mo | AMF |
| DAVID SOURDIVE | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 83ClusterFirst in 12mo | AMF |
| MARIE-BLEUENN TERRIER | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| DAVID SOURDIVE | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| ARTHUR STRIL | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| Andre Choulika | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| KYUNG NAM-WORTMAN | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| PHILIPPE DUCHATEAU | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |